Signals Regulating Vestibular Endolymph Homeostasis
Signals Regulating Vestibular Endolymph Homeostasis
批准号:
6784017
负责人:
MARK J HENKEMEYER
金额:
$35.49万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-08-01 至 2006-07-31
关键词:
biological signal transductionendolymphephrinsgene expressiongene mutationgenetically modified animalshomeostasisimmunofluorescence techniqueimmunoprecipitationlaboratory mousephosphorylationprotein protein interactionprotein tyrosine kinasereceptor expressiontranscription factorvestibular apparatus
中文摘要
描述(由申请人提供):内耳对人体健康至关重要,因为它提供听力和平衡控制所需的关键感觉信息。内耳的听觉和前庭部分是充满液体的腔室,分别用于检测声波和重力/加速度/运动。对调节内耳内淋巴液产生的分子有了更深入的了解,将有助于深入了解影响人类的听力和平衡障碍。初步研究表明,EphB2受体酪氨酸激酶突变的成年小鼠表现出与前庭功能缺陷一致的旋转运动。在相关的初步研究中,成年小鼠的同源跨膜伴侣ephrin-B2突变也被发现表现出盘旋运动。这两种突变体都显示出前庭器官内淋巴液的产生大大减少,而这些内淋巴液通常富含钾。胞内细胞外液的直接测量显示,在EphB2和ephrin-B2突变体中,内淋巴钾浓度和内淋巴电位显著降低。这种产液缺陷与EphB2在分泌性前庭暗细胞和ephrin-B2在邻近前庭移行细胞的限制性表达一致。暗细胞和移行细胞是内耳膜上皮的亚区室,在调节内淋巴液离子稳态中起重要作用。由于ephrin和Eph受体被认为在细胞-细胞信号传导中起重要作用,本应用中描述的初步数据为可能控制内淋巴液产生和稳态的信号分子提供了新的见解。重要的是,这些数据为研究前庭功能障碍提供了两种新的动物模型系统。我们计划在Specific Aims 1和2中通过在EphB2和ephrin-B2基因中产生点突变来扩展这些基因实验,以帮助确定酪氨酸激酶或PDZ信号通路是否用于内淋巴的产生。进一步的初步生化研究表明,某些结合EphB2和ephrin-B2的c端末端的PDZ结构域蛋白也能够结合其他参与调节流体稳态的膜跨越蛋白的c端末端,包括水通道蛋白水通道和阴离子交换器。在Specific Aim 3中,我们计划通过关注EphB2与维持内淋巴稳态的重要分子之间可能的物理关联来扩展这些生化研究。这里概述的遗传和生化研究的总体目标是更好地了解EphB2和ephrin-B2介导的信号传导如何与内淋巴液的产生和正常前庭功能相关。
英文摘要
DESCRIPTION (provided by applicant): The inner ear is essential for human health as it provides key sensory information required for hearing and balance control. The auditory and vestibular components of the inner ear are fluid-filled chambers that function to detect sound waves and gravity/acceleration/movement, respectively. A greater understanding of the molecules which regulate the production of the endolymph fluid in the inner ear should provide insight into hearing and balance disorders that affect the human population. Preliminary studies show that adult mice mutant for the EphB2 receptor tyrosine kinase display a circling locomotion consistent with a defect in vestibular function. In related preliminary investigations, adult mice heterozygous for a mutation in its cognate transmembrane partner, ephrin-B2, are also found to exhibit a circling locomotion. Both mutants display a much reduced production of endolymph fluid in the vestibular apparatus, which is normally rich in potassium. Direct measurement of the extracellular fluid in the utricle reveals a highly significant decrease in endolymph potassium concentration and endolymphatic potential in the EphB2 and ephrin-B2 mutants. Such a defect in fluid production is consistent with the restricted expression of EphB2 to the secretory vestibular dark cells and ephrin-B2 to adjacent vestibular transitional cells. Dark and transitional cells are subcompartments of the membranous inner ear epithelia that play important roles in regulating the ionic homeostasis of endolymph fluid. As the ephrins and Eph receptors are thought to play important roles in cell-cell signaling, the preliminary data described in this application provides novel insight into the signaling molecules that may control the production and homeostasis of endolymph fluid. Importantly, the data provide two new animal model systems to study vestibular dysfunction. We plan to expand on these genetic experiments in Specific Aims 1 and 2 by generating point mutations in the EphB2 and ephrin-B2 genes to help determine whether tyrosine kinase or PDZ signaling pathways are utilized for endolymph production. Additional preliminary biochemical studies indicate certain PDZ domain proteins that bind the C-terminal tails of both EphB2 and ephrin-B2 are also able to bind the C-terminal tails of other membrane spanning proteins implicated in regulating fluid homeostasis, including aquaporin water channels and anion exchangers. In Specific Aim 3, we plan to expand on these biochemical studies by focusing on possible physical associations of EphB2 with molecules implicated to have important roles in maintaining endolymph homeostasis. The overall objective of the genetic and biochemical studies outlined here are to obtain a better understanding how signaling mediated by EphB2 and ephrin-B2 is linked to the production of endolymph fluid and normal vestibular function.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Eph-Ephrin Bidirectional Signaling in Visual Development
-
批准号:7386598
-
项目类别:
-
资助金额:$37.35万
-
财政年份:2006
-
负责人:MARK J HENKEMEYER
-
依托单位:
Eph-Ephrin Bidirectional Signaling in Visual Development
-
批准号:7583926
-
项目类别:
-
资助金额:$38.11万
-
财政年份:2006
-
负责人:MARK J HENKEMEYER
-
依托单位:
Eph-Ephrin Bidirectional Signaling in Visual Development
-
批准号:7213274
-
项目类别:
-
资助金额:$38.11万
-
财政年份:2006
-
负责人:MARK J HENKEMEYER
-
依托单位:
Eph-Ephrin Bidirectional Signaling in Visual Development
-
批准号:7777265
-
项目类别:
-
资助金额:$37.73万
-
财政年份:2006
-
负责人:MARK J HENKEMEYER
-
依托单位:
Eph-Ephrin Bidirectional Signaling in Visual Development
-
批准号:7080035
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2006
-
负责人:MARK J HENKEMEYER
-
依托单位:
Signals Regulating Vestibular Endolymph Homeostasis
-
批准号:6671435
-
项目类别:
-
资助金额:$35.49万
-
财政年份:2003
-
负责人:MARK J HENKEMEYER
-
依托单位:
Signals Regulating Vestibular Endolymph Homeostasis
-
批准号:6927056
-
项目类别:
-
资助金额:$35.49万
-
财政年份:2003
-
负责人:MARK J HENKEMEYER
-
依托单位:
Bidirectional Tyrosine Kinase Signal Transduction
-
批准号:6699973
-
项目类别:
-
资助金额:$26.74万
-
财政年份:2002
-
负责人:MARK J HENKEMEYER
-
依托单位:
Bidirectional Tyrosine Kinase Signaling
-
批准号:8884649
-
项目类别:
-
资助金额:$52.37万
-
财政年份:2002
-
负责人:MARK J HENKEMEYER
-
依托单位:
Bidirectional Tyrosine Kinase Signaling
-
批准号:9240662
-
项目类别:
-
资助金额:$50.67万
-
财政年份:2002
-
负责人:MARK J HENKEMEYER
-
依托单位:
Bidirectional Tyrosine Kinase Signaling
-
批准号:7676070
-
项目类别:
-
资助金额:$43.18万
-
财政年份:2002
-
负责人:MARK J HENKEMEYER
-
依托单位:
Bidirectional Tyrosine Kinase Signal Transduction
-
批准号:6621963
-
项目类别:
-
资助金额:$26.74万
-
财政年份:2002
-
负责人:MARK J HENKEMEYER
-
依托单位:
Bidirectional Tyrosine Kinase Signaling
-
批准号:8761137
-
项目类别:
-
资助金额:$61.4万
-
财政年份:2002
-
负责人:MARK J HENKEMEYER
-
依托单位:
Bidirectional Tyrosine Kinase Signaling
-
批准号:8304261
-
项目类别:
-
资助金额:$40.22万
-
财政年份:2002
-
负责人:MARK J HENKEMEYER
-
依托单位:
Bidirectional Tyrosine Kinase Signaling
-
批准号:7860731
-
项目类别:
-
资助金额:$42.53万
-
财政年份:2002
-
负责人:MARK J HENKEMEYER
-
依托单位:
Bidirectional Tyrosine Kinase Signal Transduction
-
批准号:7026458
-
项目类别:
-
资助金额:$26.66万
-
财政年份:2002
-
负责人:MARK J HENKEMEYER
-
依托单位:
Bidirectional Tyrosine Kinase Signaling
-
批准号:8098790
-
项目类别:
-
资助金额:$40.88万
-
财政年份:2002
-
负责人:MARK J HENKEMEYER
-
依托单位:
Bidirectional Tyrosine Kinase Signaling
-
批准号:7533364
-
项目类别:
-
资助金额:$41.86万
-
财政年份:2002
-
负责人:MARK J HENKEMEYER
-
依托单位:
Bidirectional Tyrosine Kinase Signal Transduction
-
批准号:6438004
-
项目类别:
-
资助金额:$26.74万
-
财政年份:2002
-
负责人:MARK J HENKEMEYER
-
依托单位:
Bidirectional Tyrosine Kinase Signal Transduction
-
批准号:6864852
-
项目类别:
-
资助金额:$27.3万
-
财政年份:2002
-
负责人:MARK J HENKEMEYER
-
依托单位:
海外基金